Cibus, Inc. (CBUS) Financial Ratios
11 years of historical data (2015–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
31.44
↓-97% vs avg
5yr avg: 997.79
30Y Low0.6·High36.5
ROE
↓
-212.4%
↑-41% vs avg
5yr avg: -151.0%
30Y Low-212%·High-24%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CBUS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cibus, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $686M | $796M | $65M | $203M | $4.3B | $61.6B | $143.0B | $230.0B | $317.9B | $510.1B | — |
| Enterprise Value | $709M | $819M | $86M | $194M | $4.3B | $61.6B | $143.0B | $229.9B | $317.8B | $510.0B | — |
| P/E Ratio → | -0.54 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 188.61 | 218.79 | 15.15 | 111.49 | 27265.46 | 2370.69 | 5994.87 | 31519.68 | 1346949.25 | 1004084.47 | — |
| P/B Ratio | 31.44 | 36.47 | 0.66 | 0.60 | 591.81 | 4359.39 | 3877.54 | 3679.02 | 3403.53 | 8874.55 | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CBUS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 225.14 | 20.27 | 107.04 | 27332.24 | 2370.84 | 5994.98 | 31514.20 | 1346630.15 | 1003992.90 | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
CBUS Profitability
Margins and return-on-capital ratios measuring operating efficiency
Cibus, Inc. earns an operating margin of -1853.9%. Operating margins have expanded from -17550.0% to -1853.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -212.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -62.8% | -62.8% | 100.0% | 78.3% | -877.1% | -9.9% | -47.3% | -27.2% | -358.1% | -8.5% | 49.9% |
| Operating Margin | -1853.9% | -1853.9% | -6062.8% | -17550.0% | -14248.4% | -112.9% | -183.8% | -543.8% | -11913.1% | -5076.6% | -3034.8% |
| Net Profit Margin | -3492.3% | -3492.3% | -5898.4% | -14729.1% | -10758.6% | -112.4% | -188.0% | -542.9% | -11820.8% | -5114.2% | -3029.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -212.4% | -212.4% | -115.3% | -154.9% | -158.1% | -114.5% | -90.2% | -50.8% | -37.0% | -73.6% | -64.7% |
| ROA | -38.8% | -38.8% | -56.2% | -94.4% | -56.7% | -58.1% | -59.2% | -38.3% | -29.2% | -58.5% | -56.7% |
| ROIC | -61.5% | -61.5% | -86.2% | -137.5% | -93.5% | -76.5% | -106.3% | -146.6% | -145.2% | -203.0% | -237.0% |
| ROCE | -21.8% | -21.8% | -60.6% | -117.3% | -84.3% | -66.1% | -63.9% | -41.2% | -31.3% | -63.2% | -62.6% |
CBUS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $23M ($33M total debt minus $10M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.51 | 1.51 | 0.37 | 0.07 | 1.92 | 1.26 | 0.54 | 0.30 | 0.20 | 0.18 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 1.06 | 0.22 | -0.02 | 1.45 | 0.29 | 0.07 | -0.64 | -0.81 | -0.81 | -0.38 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -1.93 | -1.93 | -7.56 | -16.88 | -257.13 | -20.50 | -30.54 | -26.63 | -22.37 | -25789.00 | -2421.80 |
CBUS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.72x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.65x to 0.72x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.72 | 0.72 | 0.85 | 1.65 | 2.49 | 3.13 | 5.70 | 8.83 | 13.64 | 13.51 | 1.91 |
| Quick Ratio | 0.72 | 0.72 | 0.85 | 1.65 | 2.49 | 3.13 | 5.50 | 8.47 | 13.45 | 13.51 | 1.91 |
| Cash Ratio | 0.59 | 0.59 | 0.73 | 1.53 | 2.06 | 2.85 | 4.18 | 8.14 | 13.39 | 13.32 | 1.75 |
| Asset Turnover | — | 0.01 | 0.01 | 0.00 | 0.01 | 0.70 | 0.38 | 0.08 | 0.00 | 0.01 | 0.02 |
| Inventory Turnover | — | — | — | — | — | — | 25.40 | 3.58 | 0.82 | — | — |
| Days Sales Outstanding | — | 70.51 | 89.15 | 106.47 | — | — | 74.79 | 56.13 | 71.14 | 119.99 | 143.62 |
CBUS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cibus, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $458M | $23M | $10M | $578M | $578M | $678M | $656M | $614M | $463M | $532M |
Peer Comparison
Compare CBUS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CBUSYou | $686M | -0.5 | — | — | -62.8% | -1853.9% | -212.4% | -61.5% | — |
 PGEN | $1B | -8.8 | — | — | -8.7% | -3440.2% | -160.8% | -152.8% | — |
 RKDA | $2M | -0.6 | — | — | 36.2% | -205.7% | -45.1% | -249.2% | — |
 SEED | $9M | -1.1 | — | — | 7.0% | -58.9% | — | — | — |
 APLD | $12B | -35.8 | 1099.7 | — | 10.5% | -33.5% | -60.9% | -7.3% | 61.9 |
 OFIX | $488M | -5.3 | — | — | 67.1% | -8.3% | -19.3% | -8.6% | — |
 CTVA | $53B | 49.4 | 13.4 | 18.9 | 43.6% | 15.1% | 4.5% | 8.5% | 0.7 |
 FMC | $2B | -0.8 | — | — | 37.0% | -54.4% | -67.8% | -21.2% | — |
 BIOX | $30M | -0.6 | 20.0 | 0.9 | 39.1% | -1.1% | -16.0% | -0.5% | 20.2 |
 AMTX | $213M | -2.4 | — | — | -0.4% | -17.9% | — | -70.3% | — |
 DE | $157B | 31.4 | 20.0 | 48.7 | 36.5% | 18.8% | 19.3% | 7.7% | 6.0 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
See CBUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CBUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CBUS vs PGEN
Side-by-side business, growth, and profitability comparison vs Precigen, Inc..
Start ComparisonCBUS — Frequently Asked Questions
Quick answers to the most common questions about buying CBUS stock.
What is Cibus, Inc.'s P/E ratio?
Cibus, Inc.'s current P/E ratio is -0.5x. This places it at the 50th percentile of its historical range.
What is Cibus, Inc.'s ROE?
Cibus, Inc.'s return on equity (ROE) is -212.4%. The historical average is -99.6%.
Is CBUS stock overvalued?
Based on historical data, Cibus, Inc. is trading at a P/E of -0.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Cibus, Inc.'s profit margins?
Cibus, Inc. has -62.8% gross margin and -1853.9% operating margin.